Review



vivobrite rapid antibody labeling kit  (Biotium)


Bioz Verified Symbol Biotium is a verified supplier
Bioz Manufacturer Symbol Biotium manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Biotium vivobrite rapid antibody labeling kit
    Vivobrite Rapid Antibody Labeling Kit, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vivobrite rapid antibody labeling kit/product/Biotium
    Average 93 stars, based on 3 article reviews
    vivobrite rapid antibody labeling kit - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    90
    ATCC negative n 163 1
    Negative N 163 1, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/negative n 163 1/product/ATCC
    Average 90 stars, based on 1 article reviews
    negative n 163 1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Biotium vivobrite rapid antibody labeling kit
    Vivobrite Rapid Antibody Labeling Kit, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vivobrite rapid antibody labeling kit/product/Biotium
    Average 93 stars, based on 1 article reviews
    vivobrite rapid antibody labeling kit - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    92
    Novus Biologicals rabbit anti atp12a
    Rabbit Anti Atp12a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti atp12a/product/Novus Biologicals
    Average 92 stars, based on 1 article reviews
    rabbit anti atp12a - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    85
    Thermo Fisher c_____92160_10
    C 92160 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c_____92160_10/product/Thermo Fisher
    Average 85 stars, based on 1 article reviews
    c_____92160_10 - by Bioz Stars, 2026-02
    85/100 stars
      Buy from Supplier

    85
    Thermo Fisher snp fkbp5 c 92160 10
    Snp Fkbp5 C 92160 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/snp fkbp5 c 92160 10/product/Thermo Fisher
    Average 85 stars, based on 1 article reviews
    snp fkbp5 c 92160 10 - by Bioz Stars, 2026-02
    85/100 stars
      Buy from Supplier

    93
    Biotium cf680
    IL-2c immunoPET/CT in tumor-bearing mice and analyses of IL-2c target binding in blood, spleen, and tumor. a Flow cytometry analysis of CD122+ tumor-resident leukocytes 5 days after hRT in mice with or without depletion of CD122+ cells. b , c Mice bearing an s.c. B16 tumor were locally irradiated with 2 × 12 Gy when their volume reached 400 mm 3 . Five days later, they received 5 μg 64 Cu-NOTA-IL-2c (~ 7.5 MBq) and PET images were acquired 24 h later. b Representative coronal and transverse IL-2c immunoPET/CT sections are shown. White ticks in the C-sections indicate the positions of the T-sections. c Ex vivo biodistribution of radiotracer uptake 24 h p.i. in irradiated tumors of CD122-depleted and non-depleted mice. d Binding of <t>IL-2c-CF680</t> with CD122+ NK and CD8+ T cells in vivo. IL-2c-CF680 was injected i.v. 24 h before. In the upper right quadrant of the NK1.1/CD122 plots, the proportions of CD122+ cells within NK1.1+ CD3– cells (i.e., NK cells) and CD8+ CD3+ cells (i.e., CD8+ T cells), respectively, are given. The proportion of CD122+ cells bound by the i.v. injected CF680-labeled IL-2c is given in the CF680/CD122 plots. e Proportion of IL-2-secreting CD45+ cells in spleen, lymph nodes, and tumor. f Demonstration that pretreatment with IL-2 strongly reduces the binding of IL-2c to CD122+ cells. Splenocytes were collected from naïve mice. In the blocking setting, CD8+ splenocytes were incubated with IL-2 or (for control) with interferon-β at 37 °C for 30 min. Thereafter, the binding of IL-2c to CD122-positive T cells was determined by flow cytometry
    Cf680, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cf680/product/Biotium
    Average 93 stars, based on 1 article reviews
    cf680 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Stallergenes sa cockroach 92160
    IL-2c immunoPET/CT in tumor-bearing mice and analyses of IL-2c target binding in blood, spleen, and tumor. a Flow cytometry analysis of CD122+ tumor-resident leukocytes 5 days after hRT in mice with or without depletion of CD122+ cells. b , c Mice bearing an s.c. B16 tumor were locally irradiated with 2 × 12 Gy when their volume reached 400 mm 3 . Five days later, they received 5 μg 64 Cu-NOTA-IL-2c (~ 7.5 MBq) and PET images were acquired 24 h later. b Representative coronal and transverse IL-2c immunoPET/CT sections are shown. White ticks in the C-sections indicate the positions of the T-sections. c Ex vivo biodistribution of radiotracer uptake 24 h p.i. in irradiated tumors of CD122-depleted and non-depleted mice. d Binding of <t>IL-2c-CF680</t> with CD122+ NK and CD8+ T cells in vivo. IL-2c-CF680 was injected i.v. 24 h before. In the upper right quadrant of the NK1.1/CD122 plots, the proportions of CD122+ cells within NK1.1+ CD3– cells (i.e., NK cells) and CD8+ CD3+ cells (i.e., CD8+ T cells), respectively, are given. The proportion of CD122+ cells bound by the i.v. injected CF680-labeled IL-2c is given in the CF680/CD122 plots. e Proportion of IL-2-secreting CD45+ cells in spleen, lymph nodes, and tumor. f Demonstration that pretreatment with IL-2 strongly reduces the binding of IL-2c to CD122+ cells. Splenocytes were collected from naïve mice. In the blocking setting, CD8+ splenocytes were incubated with IL-2 or (for control) with interferon-β at 37 °C for 30 min. Thereafter, the binding of IL-2c to CD122-positive T cells was determined by flow cytometry
    Cockroach 92160, supplied by Stallergenes sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cockroach 92160/product/Stallergenes sa
    Average 90 stars, based on 1 article reviews
    cockroach 92160 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    IL-2c immunoPET/CT in tumor-bearing mice and analyses of IL-2c target binding in blood, spleen, and tumor. a Flow cytometry analysis of CD122+ tumor-resident leukocytes 5 days after hRT in mice with or without depletion of CD122+ cells. b , c Mice bearing an s.c. B16 tumor were locally irradiated with 2 × 12 Gy when their volume reached 400 mm 3 . Five days later, they received 5 μg 64 Cu-NOTA-IL-2c (~ 7.5 MBq) and PET images were acquired 24 h later. b Representative coronal and transverse IL-2c immunoPET/CT sections are shown. White ticks in the C-sections indicate the positions of the T-sections. c Ex vivo biodistribution of radiotracer uptake 24 h p.i. in irradiated tumors of CD122-depleted and non-depleted mice. d Binding of IL-2c-CF680 with CD122+ NK and CD8+ T cells in vivo. IL-2c-CF680 was injected i.v. 24 h before. In the upper right quadrant of the NK1.1/CD122 plots, the proportions of CD122+ cells within NK1.1+ CD3– cells (i.e., NK cells) and CD8+ CD3+ cells (i.e., CD8+ T cells), respectively, are given. The proportion of CD122+ cells bound by the i.v. injected CF680-labeled IL-2c is given in the CF680/CD122 plots. e Proportion of IL-2-secreting CD45+ cells in spleen, lymph nodes, and tumor. f Demonstration that pretreatment with IL-2 strongly reduces the binding of IL-2c to CD122+ cells. Splenocytes were collected from naïve mice. In the blocking setting, CD8+ splenocytes were incubated with IL-2 or (for control) with interferon-β at 37 °C for 30 min. Thereafter, the binding of IL-2c to CD122-positive T cells was determined by flow cytometry

    Journal: Journal for Immunotherapy of Cancer

    Article Title: Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation

    doi: 10.1186/s40425-019-0537-9

    Figure Lengend Snippet: IL-2c immunoPET/CT in tumor-bearing mice and analyses of IL-2c target binding in blood, spleen, and tumor. a Flow cytometry analysis of CD122+ tumor-resident leukocytes 5 days after hRT in mice with or without depletion of CD122+ cells. b , c Mice bearing an s.c. B16 tumor were locally irradiated with 2 × 12 Gy when their volume reached 400 mm 3 . Five days later, they received 5 μg 64 Cu-NOTA-IL-2c (~ 7.5 MBq) and PET images were acquired 24 h later. b Representative coronal and transverse IL-2c immunoPET/CT sections are shown. White ticks in the C-sections indicate the positions of the T-sections. c Ex vivo biodistribution of radiotracer uptake 24 h p.i. in irradiated tumors of CD122-depleted and non-depleted mice. d Binding of IL-2c-CF680 with CD122+ NK and CD8+ T cells in vivo. IL-2c-CF680 was injected i.v. 24 h before. In the upper right quadrant of the NK1.1/CD122 plots, the proportions of CD122+ cells within NK1.1+ CD3– cells (i.e., NK cells) and CD8+ CD3+ cells (i.e., CD8+ T cells), respectively, are given. The proportion of CD122+ cells bound by the i.v. injected CF680-labeled IL-2c is given in the CF680/CD122 plots. e Proportion of IL-2-secreting CD45+ cells in spleen, lymph nodes, and tumor. f Demonstration that pretreatment with IL-2 strongly reduces the binding of IL-2c to CD122+ cells. Splenocytes were collected from naïve mice. In the blocking setting, CD8+ splenocytes were incubated with IL-2 or (for control) with interferon-β at 37 °C for 30 min. Thereafter, the binding of IL-2c to CD122-positive T cells was determined by flow cytometry

    Article Snippet: In vivo IL-2c binding specificity was tested with the same mAb labeled with CF680 (CF680 VivoBrite Rapid Antibody Labeling Kits for Small Animal In Vivo Imaging, Biotium) according to the manufacturer’s instructions.

    Techniques: Binding Assay, Flow Cytometry, Irradiation, Ex Vivo, In Vivo, Injection, Labeling, Blocking Assay, Incubation